Complementary and Emerging Approaches: Levels of Evidence

In this chapter, we'll look at the complementary, alternative, and newly developed approaches that families often come across and wonder about — being honest about how strong the evidence is for each. Our goal is neither to reject them out of hand nor to raise exaggerated hopes; our goal is to help you make informed, realistic decisions in this area.

Questions to Ask When Judging the Evidence

• How many independent, controlled studies support this approach?
• Do the studies include a placebo or comparison group, or do they rely only on before-and-after observations?
• Have the results been reproduced by independent research groups?
• Does the approach have any known side effects or risk profile?
• Do the people recommending this approach have a direct commercial interest in the outcome?

• Commonly Asked-About Complementary Approaches
• Hyperbaric Oxygen Therapy

Although it's recommended at some centers, there isn't enough current scientific evidence that hyperbaric oxygen therapy improves the core features of autism; large-scale, controlled studies have not shown a consistent benefit.

Chelation Therapy

Chelation therapy, recommended on the claim of "removing heavy metals from the body," has no scientific basis in autism and is not recommended because of serious risks of side effects (kidney damage, calcium imbalance, and cases of death).

Hormone and Vitamin Supplement Therapies (Orthomolecular Approaches)

Correcting specific vitamin and cofactor deficiencies (such as a B6–magnesium combination, vitamin D, or omega-3 fatty acids) can support overall health when a genuine underlying deficiency is found, and in some children may contribute to behavioral regulation. However, the evidence that these approaches change the core features of autism is limited and mixed. Such supplements should be considered on the basis of a real, lab-confirmed deficiency, under a doctor's supervision, and with realistic expectations.

The Etiological Approach: Targeting the Mechanism, Not Just the Symptom

Most of the behavioral, educational, and language-based approaches we've discussed so far in this part directly target the observed behavior (communication difficulty, repetitive movement, sensory overload). The etiological, or mechanism-based, approach asks a different question: Can we regulate the underlying biological processes themselves — the excitation–inhibition (glutamate–GABA) imbalance, neuroinflammation, and differences in synaptic connectivity that we discussed in Chapter 1? The logic behind this approach rests on the assumption that when the underlying neurobiological ground is regulated somewhat, the behavioral and educational interventions built on top of it can work more effectively, and the child's openness to learning and therapy (the window of neuroplasticity) can widen.

It's important to be clear here: these approaches don't replace behavioral and educational interventions; they're positioned as a complementary layer that aims to increase their effectiveness. In our clinical practice, we plan these two layers — mechanism-based support and intensive rehabilitation — together, so that they reinforce one another.

The Stem Cell Mechanism: How Does It Work?

The rationale for stem cell–based approaches in autism rests less on the cells directly "settling" into the brain and becoming neurons, and more on the paracrine (secretory) effect that current research highlights. Mesenchymal stem cells secrete a rich "secretome" of growth factors, cytokines, and microRNAs in the tissue where they're applied; this secretion profile is thought to work through three main mechanisms:

• Immunomodulation — it may have a balancing effect on the overactivated microglia and neuroinflammatory cytokine profile (described in some children with autism).
• Trophic support — by increasing the release of neural growth factors such as BDNF (brain-derived neurotrophic factor), it may support synaptic maturation and connectivity.
• Microenvironment regulation — it may help make a damaged or functionally suppressed tissue microenvironment more receptive to repair and reorganization.

Today, applications have shifted away from transplanting live cells directly and toward the extracellular vesicles these cells produce — exosomes — because exosomes carry the same secretome content while avoiding some of the risks of live cell transplantation (immune rejection, uncontrolled proliferation).

Exosomes: Definition and the Logic of Their Use

Exosomes are nanometer-sized extracellular vesicles that cells naturally secrete, carrying growth factors, cytokines, and microRNA/mRNA inside them. Using this "secretion package" instead of the stem cell itself makes it possible to deliver a significant part of the biological effect of cell therapy in a more controlled and standardizable form. Application is typically done through the intranasal route; this is a non-invasive route that partly crosses the blood–brain barrier and eases access to the central nervous system.

Exosome Types and Selection Based on the Clinical Profile

Each of the exosome sources we use in our clinical practice has a different secretion profile, and therefore a different clinical target. For this reason, rather than a "one type of exosome for everyone" approach, choosing the source based on the child's dominant clinical profile (is it mainly inflammation-driven, mainly structural/resistant to rehabilitation, or mainly in need of neuromodulation?) is an approach that strengthens the rationale of the treatment:

• EXO1 (Wharton's jelly–derived, umbilical cord) — has a secretion profile weighted toward neuromodulation; preferred in cases where synaptic signaling and behavioral regulation are in the foreground.
• EXO2 (umbilical cord blood cell–derived) — has a pronounced anti-inflammatory effect; preferred in cases thought to have a more dominant active inflammatory component.
• EXO3 (dental-derived MSC) — its regenerative profile stands out; considered in situations where tissue repair is the main target.
• EXO4 (placenta/chorion-derived MSC) — with its high microRNA/mRNA load, it offers both a strong anti-inflammatory and a strong regenerative effect, and is effective in microenvironment modulation; it's the source we prefer first in severe, rehabilitation-resistant cases where inflammation is dominant, and in cases with a genetic/metabolic basis.
• R-EXO (umbilical cord MSC–derived) — stands out with its extracellular matrix (ECM) support and its antifibrotic and regenerative profile; preferred in cases where the need for structural repair is in the foreground.

Info Box — Why Personalized Selection Instead of One Type?

Even when two children carry the same autism diagnosis, one may present mainly with an inflammatory picture and the other mainly with a structural/regenerative need. Choosing the exosome source based on the child's clinical profile — just like choosing the active ingredient of a medication based on the target — keeps the treatment rationale in line with the principles of personalized medicine. This selection is made alongside a detailed clinical evaluation, developmental scales (Vineland-3, ADOS-2), and lab findings when needed.

Photobiomodulation (Laser): A "Priming" Tool Before Therapy

Photobiomodulation (low-level laser/LED application) is a non-invasive method in which light at certain wavelengths is thought to stimulate the cytochrome c oxidase enzyme in the mitochondria — the cell's energy plant — to increase ATP production, and also to regulate local blood flow and neuroinflammation. In brain-related applications, the aim is to temporarily increase cortical activation and metabolic efficiency, setting the stage for the learning-based interventions that follow immediately afterward.

In our clinical practice, we position photobiomodulation as a "priming" tool, especially right before education and occupational therapy sessions: the laser applied before a session temporarily increases cortical excitability and attention capacity, aiming to help the child benefit more from the structured learning environment that comes right after. This sequencing logic — neurophysiological priming first, then intensive therapeutic input — is a concrete example of how the mechanism-based approach aims to strengthen behavioral and educational intervention.

Transcranial Magnetic Stimulation (TMS): Targeted Neuromodulation

TMS is a non-invasive neuromodulation method that aims to regulate the excitation–inhibition balance in the brain (Chapter 1) in a way specific to a target region. Pulses of a magnetic field, from outside the skull, can either increase or decrease the excitability of the targeted cortical region; this makes TMS an "adjustable" tool depending on the specific clinical goal.

Two clinical targets stand out in particular in the use of TMS in autism:

• Its possible effect on repetitive behaviors — targeting regions linked to the supplementary motor area (SMA) and the orbitofrontal-striatal loops has been associated in some small-scale studies with a reduction in repetitive behavior and insistence on sameness; the rationale rests on regulating the overexcitability in these loops.
• Its supportive effect on speech and language education — targeting the language networks in and around Broca's area in the left hemisphere is thought to increase cortical excitability and thereby create a supportive ground for learning capacity and neuroplasticity during the speech and language therapy (Chapter 22) session that follows immediately afterward; for this reason, TMS sessions can be scheduled close in time to language therapy sessions.

What these two targets have in common is this: TMS is used not as a stand-alone "curative" endpoint, but as a neuromodulation layer that aims to increase the effectiveness of the behavioral/educational intervention (rehabilitation, language therapy) that follows. For this reason, TMS protocols are personalized through the choice of target region and parameters based on the child's individual clinical goal (whether repetitive behavior or language development is in the foreground).

Info Box — An Honest Note on the Evidence

The mechanistic rationale for stem cell/exosome and TMS-based approaches is strong and increasingly well understood; however, large-scale, multi-center, double-blind placebo-controlled studies are still limited in this area. This doesn't mean the approaches are ineffective — but families are encouraged to consider these options at an experienced child neurology center, after a detailed clinical evaluation, with realistic expectations, and together with (not in place of) existing behavioral and educational interventions.

Caution / When to Consult a Professional

Be wary of any approach that makes promises like "completely cures autism," "guaranteed definite results," or "change in a single session." Serious scientific approaches always acknowledge individual variation and offer realistic, measured expectations; a promise of certainty is usually a warning sign.

Suggestions for Families When Evaluating New Approaches

If you're considering any complementary or new approach, evaluate it not in place of existing evidence-based treatments (behavioral, educational, language-based interventions), but together with them, and by talking openly with the child neurologist or developmental pediatrician who follows your child. Transparent doctor-family communication both ensures safety and helps you direct your resources (time, effort, money) toward the approaches that will provide the most benefit.

Info Box — Closing of Part Seven

No complementary approach should replace evidence-based behavioral, educational, and language-based interventions.

When judging the evidence, question the quality of the study, its reproducibility, and any conflict of interest on the part of those recommending it.

Be wary of approaches that promise certainty and miraculous results.

When evaluating new and research-stage approaches (such as stem cell/exosome or TMS), keep an open and transparent dialogue with the specialist who follows your child.